Boston Scientific Carotid WALLSTENT Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice

Boston Scientific Corporation

reports positive outcomes from the CABANA post-approval study of the  Carotid WALLSTENT ^ Monorail ^ Endoprosthesis used in conjunction with its FilterWire EZ™ Embolic Protection System in routine clinical practice.  Multi-center registry results demonstrate that carotid artery stenting with Carotid WALLSTENT and FilterWire EZ is a safe alternative to carotid endarterectomy in patients with carotid artery stenosis who are at increased risk for surgery.  The analysis was presented today by L. Nelson Hopkins, M.D., Chairman of Neurosurgery at the State University of New York in Buffalo, Trial Investigator and Advisory Committee member, at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics scientific symposium in San Francisco.